Language:
Daily summary of financings for therapeutic biotechnology company executives and investors
Thursday, August 14, 2025
Wednesday, August 13, 2025
Hatteras’s $200 Million Fund Raise
X4’s $85 Million Private Placement
Tuesday, August 12, 2025
Bayer’s $1.3 Billion Acquisition of Kumquat
Portal’s $100 Million Fund Raise
Mabylon’s $37 Million Fund Raise
Jocasta’s $35 Million Series A
BioVie’s $12 Million Public Offering
Monday, August 11, 2025
Ligand’s $400 Million Debt Financing
180’s $156 Million Debt Financing…More
Saturday, August 9, 2025
Longeveron’s $17 Million Public Offering
Friday, August 8, 2025
Assembly’s $175 Million Equity Investment
Fractyl’s $23 Million Public Offering
Ocugen’s $20 Million Registered Direct Offering
Nicox’s $4 Million Equity Investment
Thursday, August 7, 2025
Strand’s $153 Million Series B
Minghui’s $131 Million Pre-IPO
Fractyl’s $23 Million Public Offering
Belite’s $15 Million Registered Direct Offering
Wednesday, August 6, 2025
Chai Discover’s $70 Million Series A
Retension’s $15 Million Series B
Tuesday, August 5, 2025
MEI’s $100 Million Acquisition of Litecoin
Shattuck’s $30 Million Private Placement
Monday, August 4, 2025
OrbiMed’s $1.86 Billion Fund Raise
180’s $425 Million Private Placement
XOMA’s $103 Million Acquisition of HilleVax
Oculis’s $92 Million Debt Financing
Artelo’s $10 Million Private Placement
Intensity’s $7 Million Fund Raise
Silexion’s $2 Million Warrant Exercise
Saturday, August 2, 2025
PNP Program Partners
In coordination with an executive placement firm that is independent and unaffiliated with Collabrity, Inc., we may coordinate with executive(s) who are sourced by that firm and also independent and unaffiliated with Collabrity, Inc.: “Collabrity Executive(s)” does not imply an employment or independent contractor relationship with Collabrity, Inc.
Securities offered through Finalis Securities LLC Member FINRA / SIPC. Collabrity Inc. is not a registered broker-dealer, and Finalis Securities LLC and Collabrity Inc. are separate, unaffiliated entities. Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck